UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                        Commission File Number: 000-33067

                             CUSIP Number: 70322H106

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING


     (Check One): [ ] Form 10-K and Form 10-KSB [ ] Form 20-F [ ] Form 11-K

                  [X] Form 10-Q and Form 10-QSB [ ] Form N-SAR

      For Period Ended: June 30, 2006

      [  ] Transition Report on Form 10-K   [  ] Transition Report on Form 10-Q
      [  ] Transition Report on Form 20-F   [  ] Transition Report on Form N-SAR
      [  ] Transition Report on Form 11-K

      For the Transition Period Ended :________________________

      Read attached instruction sheet before preparing form. Please print or
type.

      Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

      If the notification related to a portion of the filing checked above,
identify the item(s) to which the notification relates:




                                     PART I
                             REGISTRANT INFORMATION


Full name of registrant:    Patient Safety Technologies, Inc.

Former name if applicable: ___________________________________________

Address of principal executive office (street and number): 1800 Century Park
                                                           East, Suite 200

City, state and zip code: Los Angeles, California 90067


                                     PART II
                             RULE 12b-25 (b) and (c)

      If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate.)

|X|         (a)   The reasons described in reasonable detail in Part III of this
                  form could not be eliminated without unreasonable effort or
                  expense.

|X|         (b)   The subject annual report, semi-annual report, transition
                  report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion
                  thereof will be filed on or before the fifteenth calendar day
                  following the prescribed due date; or the subject quarterly
                  report or transition report on Form 10-Q or portion thereof
                  will be filed on or before the fifth calendar day following
                  the prescribed due date; and

            (c)   The accountant's statement or other exhibit required by Rule
                  12b-25(c)has been attached if applicable.


                                    PART III
                                    NARRATIVE


      State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F,
10-Q, N-SAR or the transition report portion thereof could not be filed within
the prescribed time period.

      The Company's Quarterly Report on Form 10-QSB for the quarterly period
ended June 30, 2006 cannot be filed within the prescribed time period because
the Company requires additional time for compilation and review to insure
adequate disclosure of certain information required to be included in the Form
10-QSB. The Company's Quarterly Report on Form 10-QSB will be filed on or before
the 5th calendar day following the prescribed due date.

                                        2


                                     PART IV
                                OTHER INFORMATION


(1)   Name and telephone number of person to contact in regard to this
      notification:

      William B. Horne, Chief Financial Officer, (310) 895-7750
      ---------------------------------------------------------

(2)   Have all other periodic reports required under Section 13 or 15(d) of the
      Securities Exchange Act of 1934 or Section 30 of the Investment Company
      Act of 1940 during the preceding 12 months or for such shorter period that
      the registrant was required to file such report(s) been filed? If the
      answer is no, identify report(s)
                                                                  [X] Yes [ ] No

(3)   Is it anticipated that any significant change in results of operations
      from the corresponding period for the last fiscal year will be reflected
      by the earnings statements to be included in the subject report or portion
      thereof?

                                                                  [X] Yes [ ] No

      If so, attach an explanation of the anticipated change, both narratively
      and quantitatively, and, if appropriate, state the reason why a reasonable
      estimate of the results cannot be made.

      Patient Safety Technologies, Inc. (the "Company") anticipates that its
      revenue for the three and six months ended June 30, 2006 is significantly
      less that its revenue for the three and six months ended June 30, 2005.
      The decrease in revenue is primarily the result of the transfer to the
      Company of 500,000 shares of common stock of IPEX, Inc. ("IPEX") in
      exchange for consulting services rendered by the Company to IPEX during
      the quarter ended June 30, 2005. The Company anticipates that its
      operating expenses and net loss for the three and six months ended June
      30, 2006 are significantly greater than the expenses and net loss for the
      three and six months ended June 30, 2005. The increase in operating
      expenses for the three and six months ended June 30, 2006 when compared to
      June 30, 2005, was primarily the result of stock based compensation
      expenses, and to a lesser extent salaries and employee benefits, and
      interest expense. Net loss increased for the three and six months ended
      June 30, 2006 compared to the three and six months ended June 30, 2005
      primarily as a result of a significant increase in operating expenses.

      A reasonable estimate of the results cannot be made at this time due to
      the fact that the compilation, dissemination and review of the information
      required to be presented in the Form 10-Q has not been completed.

                                        3


                        Patient Safety Technologies, Inc.
                  --------------------------------------------
                  (Name of Registrant as specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date: August 14, 2006                       By:  /s/ William B. Horne
      ---------------                            -----------------------
                                                 William B. Horne
                                                 Chief Financial Officer





                                        4